Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis

Signe Wildt; Lars K Munck; Lars Vinter-Jensen; Birgit Fischer Hanse; Inge Nordgaard-Lassen; Steen Christensen; Soeren Avnstroem; Sten Noerby Rasmussen; Jüri J Rumessen; Inge Nordgaard Lassen

doi:10.1097/01.MIB.0000218763.99334.49

Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis

Signe Wildt
, Lars K Munck
, Lars Vinter-Jensen
, Birgit Fischer Hanse
, Inge Nordgaard-Lassen
, Steen Christensen
, Soeren Avnstroem
, Sten Noerby Rasmussen
, Jüri J Rumessen
, Inge Nordgaard Lassen

Research output: Contribution to journal › Journal article › Research › peer-review

Abstract

Probiotic treatment may be effective in diseases involving gut microflora and intestinal inflammation. In collagenous colitis (CC), a potential pathogenic role of the gut microflora has been proposed. The effect of probiotic treatment in CC is unknown. Our aim was to investigate the clinical effect of treatment with Lactobacillus acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 (AB-Cap-10) in patients with CC.

Original language	English
Journal	Inflammatory Bowel Diseases
Volume	12
Issue number	5
Pages (from-to)	395-401
Number of pages	7
ISSN	1078-0998
DOIs	https://doi.org/10.1097/01.MIB.0000218763.99334.49
Publication status	Published - 1 May 2006

Access to Document

10.1097/01.MIB.0000218763.99334.49

Library access?

Check availability at the Royal Danish Library

Cite this

Wildt, S., Munck, L. K., Vinter-Jensen, L., Hanse, B. F., Nordgaard-Lassen, I., Christensen, S., Avnstroem, S., Rasmussen, S. N., Rumessen, J. J., & Lassen, I. N. (2006). Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. Inflammatory Bowel Diseases, 12(5), 395-401. https://doi.org/10.1097/01.MIB.0000218763.99334.49

Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis. / Wildt, Signe; Munck, Lars K; Vinter-Jensen, Lars et al.
In: Inflammatory Bowel Diseases, Vol. 12, No. 5, 01.05.2006, p. 395-401.

Research output: Contribution to journal › Journal article › Research › peer-review

Wildt, S, Munck, LK, Vinter-Jensen, L, Hanse, BF, Nordgaard-Lassen, I, Christensen, S, Avnstroem, S, Rasmussen, SN, Rumessen, JJ & Lassen, IN 2006, 'Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis', Inflammatory Bowel Diseases, vol. 12, no. 5, pp. 395-401. https://doi.org/10.1097/01.MIB.0000218763.99334.49

@article{ffe0657a3ab04bf9b022f1dbc0c3f3ce,

title = "Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis",

abstract = "Probiotic treatment may be effective in diseases involving gut microflora and intestinal inflammation. In collagenous colitis (CC), a potential pathogenic role of the gut microflora has been proposed. The effect of probiotic treatment in CC is unknown. Our aim was to investigate the clinical effect of treatment with Lactobacillus acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 (AB-Cap-10) in patients with CC.",

author = "Signe Wildt and Munck, \{Lars K\} and Lars Vinter-Jensen and Hanse, \{Birgit Fischer\} and Inge Nordgaard-Lassen and Steen Christensen and Soeren Avnstroem and Rasmussen, \{Sten Noerby\} and Rumessen, \{J{\"u}ri J\} and Lassen, \{Inge Nordgaard\}",

year = "2006",

month = may,

day = "1",

doi = "10.1097/01.MIB.0000218763.99334.49",

language = "English",

volume = "12",

pages = "395--401",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis

AU - Wildt, Signe

AU - Munck, Lars K

AU - Vinter-Jensen, Lars

AU - Hanse, Birgit Fischer

AU - Nordgaard-Lassen, Inge

AU - Christensen, Steen

AU - Avnstroem, Soeren

AU - Rasmussen, Sten Noerby

AU - Rumessen, Jüri J

AU - Lassen, Inge Nordgaard

PY - 2006/5/1

Y1 - 2006/5/1

N2 - Probiotic treatment may be effective in diseases involving gut microflora and intestinal inflammation. In collagenous colitis (CC), a potential pathogenic role of the gut microflora has been proposed. The effect of probiotic treatment in CC is unknown. Our aim was to investigate the clinical effect of treatment with Lactobacillus acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 (AB-Cap-10) in patients with CC.

AB - Probiotic treatment may be effective in diseases involving gut microflora and intestinal inflammation. In collagenous colitis (CC), a potential pathogenic role of the gut microflora has been proposed. The effect of probiotic treatment in CC is unknown. Our aim was to investigate the clinical effect of treatment with Lactobacillus acidophilus LA-5 and Bifidobacterium animalis subsp. lactis BB-12 (AB-Cap-10) in patients with CC.

U2 - 10.1097/01.MIB.0000218763.99334.49

DO - 10.1097/01.MIB.0000218763.99334.49

M3 - Journal article

SN - 1078-0998

VL - 12

SP - 395

EP - 401

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

IS - 5

ER -